Cite
HARVARD Citation
Kan, H. et al. (2013). THU0261 Outcomes in Systemic Lupus Erythematous (SLE) Patients with High Disease Activity Treated with Belimumab: Results from an Observational Study in the United States (U.S.). Annals of the rheumatic diseases. pp. A253-A254. [Online].